EUR vs Niger: Hepatitis B surface antigen (HBsAg) prevalence
EUR
0.1%
in 2024
Niger
3.2%
in 2024
EUR rank
6th
Niger rank
3rd
Hepatitis B surface antigen (HBsAg) prevalence over time
- EUR
- Niger
How they compare
Niger currently reports 3.2% against 0.1% in EUR, a difference of 3.1%.
That makes Niger's figure about 32.0 times EUR's.
Across all 10 years both countries report, Niger has been ahead every year.
EUR ranks 6th and Niger ranks 3rd of 7 groups.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | EUR | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 2.6% | 2.5% | Niger |
| 2020s | 0.1% | 3.4% | 3.3% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, EUR or Niger?
- Niger, at 3.2% against 0.1% in EUR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between EUR and Niger?
- 3.1%, with Niger ahead.
- How many years of comparable data are there for EUR and Niger?
- 10 years are reported by both, from 2015 to 2024.
- How do EUR and Niger rank globally for hepatitis b surface antigen (hbsag) prevalence?
- EUR ranks 6th and Niger ranks 3rd of 7 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.